Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pill oesophagitis caused by potassium chloride |
Causative agent (attribute) |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Potassium chloride 7.5% syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride I.V |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride strong 15% injection+plastic snaps (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride strong 15% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/15mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1g/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1g/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/15m solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.5g/unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10 meq750 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 20 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 15meq/pkg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 8 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10meq m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 750 mg10 meq tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.5g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/pkt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1500mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 8meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride 10 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20meq/10mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 4%/0.18% 13.5mmol/500mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/sodium chloride 0.9% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/sodium chloride 0.9% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 10%/0.45% 10mmol/500mL infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride injection solution ampoule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20% injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Normal saline + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10% + saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate+potassium chloride effervescent tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Potassium bicarbonate- and potassium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glucose and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Foetal intracardiac injection of potassium chloride |
Direct substance |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intracardiac potassium chloride injection (procedure) |
Direct substance |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride- and sodium chloride- and sodium lactate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Potassium chloride 600 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely potassium chloride 750 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 1.5 g prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Foetal intracardiac injection of potassium chloride |
Direct substance |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intracardiac potassium chloride injection (procedure) |
Direct substance |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing potassium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride 1.875 g oral tablet |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride 600 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium chloride 10meq prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium (K-43) chloride (substance) |
Is modification of (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium (K-42) chloride (substance) |
Is modification of (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bendroflumethiazide 2.5 mg and potassium chloride 573 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bendroflumethiazide 2.5 mg and potassium chloride 573 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Potassium chloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |